Awoniji C A, Roberts D, Chandrashekar V, Hurst B S, Tucker K E, Schlaff W D
University of Colorado Health Sciences Center, Denver 80262, USA.
J Androl. 1996 Jan-Feb;17(1):35-40.
We have previously shown that suppression of gonadotropins and spermatogenesis can be produced in rats by immunization against gonadotropin releasing hormone (GnRH). Administration of testosterone (T) alone is effective in restoring complete spermatogenesis in these rats, although it is not effective in doing so in chronically treated hypophysectomized rats. This suggests that a pituitary factor(s) other than luteinizing hormone (LH) and follicle-stimulating hormone (FSH) is required to restore normal spermatogenesis. The studies described herein test the hypothesis that prolactin (PRL) is the additional requirement for complete restoration of spermatogenesis. Twenty rats were immunized against GnRH, and four groups of five each received either 1) 24-cm T-filled Silastic implant (TSl), 2) TSl plus bromocriptine pellet (B), 3) B plus empty Silastic implant (Sl), or 4) Sl alone. Five nonimmunized rats received Sl alone and served as controls. All rats were sacrificed 2 months after treatment. GnRH immunization and B administration suppressed gonadotropins and PRL levels, respectively, and advanced spermatids were not detectable in these rats. Testis weight was suppressed to about 19% of controls. The number of advanced spermatids in control rats was 220 +/- 23 x 10(6). TSl administration restored advanced spermatids to numbers comparable to controls in GnRH-immunized rats whether the rat received B (191 +/- 17 x 106) or not (217 +/- 18 x 10(6)). Additionally, we determined mRNA levels for PRL and FSH beta subunit (FSH beta) in the pituitary by Northern blot and densitometric scanning. The mRNA levels of PRL mirrored serum PRL levels, and the same was true for FSH beta subunits and serum FSH levels. These data show that suppression of PRL has no effect on the ability of T to restore complete spermatogenesis in GnRH-immunized rats. This observation mitigates against the hypothesis that PRL is the pituitary factor required to allow complete restoration of spermatogenesis to occur.
我们之前已经表明,通过免疫促性腺激素释放激素(GnRH),可以在大鼠中抑制促性腺激素和精子发生。单独给予睾酮(T)可有效恢复这些大鼠的完全精子发生,尽管在长期治疗的垂体切除大鼠中无效。这表明除黄体生成素(LH)和卵泡刺激素(FSH)之外的一种垂体因子是恢复正常精子发生所必需的。本文所述的研究检验了催乳素(PRL)是精子发生完全恢复的额外必需因素这一假设。20只大鼠接受GnRH免疫,然后将其分成四组,每组五只,分别接受:1)24厘米含T的硅橡胶植入物(TSl);2)TSl加溴隐亭丸剂(B);3)B加空硅橡胶植入物(Sl);或4)仅Sl。五只未免疫的大鼠接受仅Sl并作为对照。所有大鼠在治疗后2个月处死。GnRH免疫和给予B分别抑制了促性腺激素和PRL水平,并且在这些大鼠中未检测到晚期精子细胞。睾丸重量被抑制至对照的约19%。对照大鼠中晚期精子细胞的数量为220±23×10⁶。无论大鼠是否接受B(191±17×10⁶),给予TSl均可使GnRH免疫大鼠中的晚期精子细胞数量恢复至与对照相当的水平(217±18×10⁶)。此外,我们通过Northern印迹和光密度扫描测定了垂体中PRL和FSHβ亚基(FSHβ)的mRNA水平。PRL的mRNA水平反映血清PRL水平,FSHβ亚基和血清FSH水平也是如此。这些数据表明,抑制PRL对T恢复GnRH免疫大鼠完全精子发生的能力没有影响。这一观察结果不支持PRL是使精子发生完全恢复所需的垂体因子这一假设。